Manufacturers Life Insurance Company, The Tg Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 79,191 shares of TGTX stock, worth $2.29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,191
Previous 80,664
1.83%
Holding current value
$2.29 Million
Previous $1.44 Million
29.06%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding TGTX
# of Institutions
337Shares Held
87.7MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$444 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$329 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$263 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$103 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$92.6 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.2B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...